Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Rapport Therapeutics, Inc.
RAPP
Net margin
Net margin at other companies
Bristol-Myers Squibb
BMY
15%
+3.8pp
Supernus Pharmaceuticals
SUPN
-3.7%
-13.0pp
Xenon Pharmaceuticals
XENE
-4,612.1%
—
Praxis Precision Medicines, Inc.
PRAX
-3,658.5%
-1,388pp
Septerna, Inc.
SEPN
-49.9%
-24.9pp
PVL
Palvella Therapeutics
PVLA
71.7%
+40.4pp
Other financials
Income statement
See full
Revenue
$20.0M
—
Operating income
-$24.2M
+10.7%
Net income
-$19.9M
+17.5%
EPS (diluted)
-$0.42
+38.2%
Balance sheet
See full
Cash & equivalents
$78.1M
+35.5%
Total debt
$10.8M
+37.8%
Total equity
$471.5M
+65.0%
Total assets
$497.6M
+64.7%
Cash flow
See full
Operating cash flow
-$13.1M
+35.5%
CapEx
$86.0K
-70.4%
Free cash flow
-$13.1M
+36.0%
Valuation
See full
Market cap
$1.91B
+309%
Returns & leverage
See full
Return on equity
-28.3%
—
Debt / equity
0×
0.0×
Current ratio
27.1×
-3.9×